Video Experimental Relacionado
Updated: Sep 20, 2025
09:11
A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
Published on: August 11, 2012
13.1K
El tracoma
Esmael Habtamu1, Emma M Harding-Esch2, Katie Greenland3
1Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK; Eyu-Ethiopia, Bahir Dar, Ethiopia; Department of Ophthalmology, College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.
Lancet (London, England)
|May 24, 2025
Resumen
El tracoma, una de las principales causas de ceguera infecciosa, requiere esfuerzos continuos para su eliminación mundial para 2030. Se necesitan nuevas estrategias para abordar el tracoma activo persistente y lograr el objetivo de la Organización Mundial de la Salud
Área de la Ciencia:
- Oftalmología
- Enfermedades infecciosas
- Salud pública
Sus antecedentes:
- El tracoma es la principal causa infecciosa de ceguera a nivel mundial y un foco importante para el objetivo de eliminación de la Organización Mundial de la Salud para 2030.
- Es causada por infecciones repetidas de Chlamydia trachomatis en la infancia, lo que lleva a cicatrices en la conjuntiva y a una pérdida de visión potencialmente irreversible.
- Las poblaciones afectadas se encuentran a menudo en áreas rurales empobrecidas con acceso limitado al agua y al saneamiento, lo que afecta desproporcionadamente a las mujeres y los niños.
Objetivo del estudio:
- Revisar el progreso y los desafíos mundiales en la eliminación del tracoma como problema de salud pública.
- Destacar la eficacia de la estrategia SAFE (cirugía, antibióticos, limpieza facial, mejora del medio ambiente).
- Identificar la necesidad de enfoques nuevos o intensificados para combatir el tracoma persistente y recurrente.
Principales métodos:
- El estudio es una revisión del estado actual de los programas de eliminación de tracoma en todo el mundo.
- Analiza el impacto y el éxito de la estrategia SAFE en las últimas dos décadas.
- Identifica las áreas con tracoma activo persistente o recurrente.
Principales resultados:
- La estrategia SAFE ha dado lugar a un éxito considerable, con 21 países eliminando el tracoma para diciembre de 2024.
- Varios otros países están en camino de alcanzar pronto los objetivos de eliminación.
- Sin embargo, siguen existiendo desafíos debido al tracoma activo persistente y recurrente en ciertas poblaciones.
Conclusiones:
- Si bien se han logrado avances significativos, el objetivo global de eliminación del tracoma para 2030 enfrenta desafíos.
- El éxito continuo requiere el desarrollo y la aplicación de intervenciones nuevas o intensificadas.
- Acelerar los esfuerzos de eliminación es crucial en entornos con enfermedades persistentes.
Videos de Conceptos Relacionados
01:26Sexually Transmitted Infections
427
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
427
01:23Skin Diseases and Disorders
4.3K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.3K
01:29Bacterial Phylum Chlamydiae
124
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
124
01:25Glaucoma: Overview
796
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
796
01:22Trachea
2.8K
The trachea, commonly known as the windpipe, is a vital part of the human respiratory system. It serves as a passageway for air to travel between the larynx and the bronchi, allowing oxygen to reach the lungs. Let's explore its anatomical features, dimensions, layers of the tracheal wall, associated muscles, and the functions of its parts.
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
2.8K
01:28Angle Closure Glaucoma: Treatment
728
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
728